Arimoclomol

Chemical formula: C₁₄H₂₀ClN₃O₃  Molecular mass: 313.119 g/mol  PubChem compound: 208924

Active ingredient description

The mechanism(s) by which arimoclomol exerts its clinical effects in patients with NPC is unknown.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC Group Classification
N07XX17 N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX17

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Document Type Information Source  
 MIPLYFFA Capsule MPI, US: SPL/PLR FDA, National Drug Code (US)

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 289893-25-0
DrugBank Drug: DB05025
KEGG Drug: D11374
PubChem Compound: 208924
UNII Identifier: EUT3557RT5
ARIMOCLOMOL

Medicines

Arimoclomol is an active ingredient of these brands:

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈